Human Metabolism Lecture Notes

Total Page:16

File Type:pdf, Size:1020Kb

Human Metabolism Lecture Notes Human metabolism lecture notes Michael Palmer, MD Department of Chemistry University of Waterloo Waterloo, ON N2L 3G1 Canada [email protected] This version is from Saturday 16th February, 2019. The latest electronic version of these notes and accompanying slides is available for free at watcut.uwaterloo.ca/webnotes/Metabolism/. No other website is authorized to publicly distribute these notes or accompanying slides. A printed version used to be available, but I have discontinued it. Copyright© Michael Palmer, 2019. All rights reserved (see section 21.3 for details). Cover design by Jana Rade (impactstudiosonline.com). The cover illustration is a model of a glycogen molecule; the protein molecule at the center is glycogenin, whereas the green rods represent the branched glucose polymer. Preface These lecture notes, and the accompanying slides, are intended for teaching human metabolism at the undergraduate level. They aim to give a big picture view of the field that takes into account physiological and some clinical aspects. They also strive to be up to date. Some biochemistry texts present all the latest and greatest enzyme crystal structures, but seem stuck in the 1960s when it comes to updating metabolic pathways. It is likely that these notes are not completely free from this disease either, and I therefore welcome any corrections and suggestions for improvement. The notes and the slides are meant to be used in conjunction; the notes mostly present the slides in sequence, augmenting each with explanatory text. Keeping the figures and the corresponding text closely together may not always look as polished as a conventional book layout, but it makes on-screen reading easier. This structure also encourages me to stay on topic and to advance the plot with each successive slide. Finally, it makes it easier to recapitulate or anticipate the content of a lecture; this goes for both the students and the lecturer. Another conscious choice is to make these materials freely available. The text is entirely my own work. So is the majority of the images; all exceptions are listed in chapter 21. Regarding those images, I would like to thank all individuals and institutions who gave me permission to reuse them in these notes. In particular, I thank Katharina Glatz of Basel University for permission to use multiple histological pictures from her excellent website pathorama.ch. You are free and welcome to use these notes and slides for self-study or for classroom teaching. Some restrictions apply concerning the copying and redistribution of these materials; refer to the copyright notice in chapter 21 for details. I hope that, in return, you will bring to my attention any errors or shortcomings that you may notice. I would also like to thank my students, who have helped to improve these notes by challenging and questioning me about the material and its presentation. In particular, Stefanie Malatesta and Julia Plakhotnik have helped substantially in this manner. Finally, I thank Thorsten Dieckmann, Alexey J. Merz, and Karen Borges for pointing out errors in previous editions. These notes were put together with a collection of excellent free software tools. Apart from the well-known tools LATEX, Pymol, and Gnuplot, I must highlight the outstanding chemfig LATEX package written by Christian Tellechea that was used to draw all of the chemical structures and reaction mechanisms. iii Update 2019: New material on reactive species has been added as chapter 18. This is a fairly complex subject, and my attempt to do it justice has produced a text that may strike some fairly long. I feel, however, that this is justified, considering the extensive overlap of this topic with metabolism in health and disease. While some of the slides and text that had been present in other chapters have now been moved to this new one to limit redundancy in this text, the slides still exist (now as duplicates) in their original location in the accompanying Powerpoint and PDF slide sets so as to better maintain flow and context. iv Contents Preface......................................... iii Chapter 1 Introduction ............................. 1 1.1 Motivation: Why would you study metabolism?............. 1 1.2 Significance of metabolism in medicine ................. 1 1.3 Catabolic and anabolic reactions ..................... 2 1.4 Diversity of metabolism: pathways in plants and bacteria. 3 1.5 Types of foodstuffs ............................. 4 1.6 Functional anatomy of the digestive system............... 6 1.7 Answers to practice questions ....................... 15 Chapter 2 Refresher ............................... 17 2.1 Preliminary note ............................... 17 2.2 How enzymes work: active sites and catalytic mechanisms . 17 2.3 Energetics of enzyme-catalyzed reactions . 20 2.4 The role of ATP in enzyme-catalyzed reactions . 22 2.5 Regulation of enzyme activity ....................... 23 2.6 Answers to practice questions ....................... 28 Chapter 3 Glycolysis ............................... 30 3.1 Overview of glucose metabolism ..................... 30 3.2 Reactions in glycolysis ........................... 32 3.3 Mechanisms of enzyme catalysis in glycolysis . 34 3.4 Glycolysis under aerobic and anaerobic conditions. 39 3.5 Transport and utilization of glucose in the liver and in other organs 41 3.6 Answers to practice questions ....................... 43 Chapter 4 Catabolism of sugars other than glucose . 45 4.1 Dietary sugars other than glucose..................... 45 4.2 Degradation of fructose and sucrose ................... 46 4.3 Lactose and galactose ............................ 47 4.4 Sorbitol is an intermediate of the polyol pathway . 51 4.5 Answers to practice questions ....................... 52 v Contents Chapter 5 Pyruvate dehydrogenase and the citric acid cycle. 54 5.1 Overview ................................... 54 5.2 Structure and function of pyruvate dehydrogenase . 55 5.3 Regulation of pyruvate dehydrogenase. 59 5.4 The citric acid cycle ............................. 60 5.5 Regulation of the citric acid cycle ..................... 64 5.6 Reactions that divert and replenish TCA cycle intermediates . 65 5.7 Answers to practice questions ....................... 66 Chapter 6 The respiratory chain ........................ 67 6.1 Introduction ................................. 67 6.2 Overview ................................... 67 6.3 ATP synthesis can be separated from electron transport . 69 6.4 Molecules in the electron transport chain . 71 6.5 The energetics of electron transport ................... 75 6.6 Interfacing different types of electron carriers . 78 6.7 How is electron transport linked to proton pumping? . 81 6.8 ATP synthesis ................................ 83 6.9 Auxiliary shuttles for the mitochondrial reoxidation of cytosolic NADH ..................................... 87 6.10 Regulation of the respiratory chain .................... 90 6.11 ATP yield of complete glucose oxidation. 93 6.12 Answers to practice questions ....................... 95 Chapter 7 Gluconeogenesis ........................... 96 7.1 Introduction ................................. 96 7.2 Reactions in gluconeogenesis ....................... 97 7.3 Energy balance of gluconeogenesis . 100 7.4 Interactions of gluconeogenesis with other pathways . 101 7.5 Regulation of gluconeogenesis. 103 7.6 Answers to practice questions . 106 Chapter 8 Glycogen metabolism . 108 8.1 Overview ................................... 108 8.2 Glycogen structure ............................. 108 8.3 Glycogen synthesis and degradation . 111 8.4 Regulation of glycogen metabolism . 116 8.5 Interorgan relationships in glycogen metabolism . 118 8.6 Glycogen storage diseases . 121 8.7 Answers to practice questions . 124 Chapter 9 The hexose monophosphate shunt . 125 9.1 Outline of the pathway . 125 9.2 Reactions in the hexose monophosphate shunt . 126 9.3 The physiological role of NADPH . 130 vi Contents 9.4 Glucose-6-phosphate dehydrogenase deficiency . 136 9.5 Answers to practice questions . 138 Chapter 10 Triacylglycerol metabolism . 140 10.1 Overview ................................... 140 10.2 Digestion and uptake of dietary triacylglycerol . 142 10.3 Utilization of fatty acids: β-oxidation . 147 10.4 Ketone body metabolism . 153 10.5 Fatty acid synthesis ............................. 157 10.6 The glyoxylate cycle ............................. 164 10.7 Answers to practice questions . 165 Chapter 11 Cholesterol metabolism . 167 11.1 Biological significance of cholesterol . 167 11.2 Cholesterol synthesis ............................ 168 11.3 Regulation of cholesterol synthesis . 173 11.4 Cholesterol transport ............................ 176 11.5 Bile acid metabolism and transport . 182 11.6 Cholesterol and atherosclerosis . 185 11.7 Cholesterol metabolism and the treatment of atherosclerosis . 191 11.8 Gene defects in cholesterol transport and metabolism . 195 11.9 Answers to practice questions . 196 Chapter 12 Amino acid metabolism . 198 12.1 Metabolic uses of amino acids . 198 12.2 Transamination of amino acids . 200 12.3 Nitrogen disposal and excretion. 202 12.4 Degradative pathways of individual amino acids . 211 12.5 Hereditary enzyme defects in amino acid metabolism . 215 12.6 Answers to practice questions . 218 Chapter 13 Hormonal regulation of metabolism . 220 13.1 Hormones that affect energy metabolism . 220 13.2 Insulin..................................... 221 13.3 Other hormones ............................... 231 13.4 Answers to practice questions . 236 Chapter 14 Diabetes
Recommended publications
  • Dynamic Metabolic Zonation of the Hepatic Glucose Metabolism Is Accomplished by Sinusoidal Plasma Gradients of Nutrients and Hormones
    ORIGINAL RESEARCH published: 12 December 2018 doi: 10.3389/fphys.2018.01786 Dynamic Metabolic Zonation of the Hepatic Glucose Metabolism Is Accomplished by Sinusoidal Plasma Gradients of Nutrients and Hormones Nikolaus Berndt 1,2 and Hermann-Georg Holzhütter 1* 1 Computational Biochemistry Group, Institute of Biochemistry, Charite—University Medicine Berlin, Berlin, Germany, 2 Institute for Computational and Imaging Science in Cardiovascular Medicine, Charite—University Medicine Berlin, Berlin, Germany Being the central metabolic organ of vertebrates, the liver possesses the largest repertoire of metabolic enzymes among all tissues and organs. Almost all metabolic pathways are resident in the parenchymal cell, hepatocyte, but the pathway capacities may largely differ depending on the localization of hepatocytes within the liver acinus-a phenomenon that is commonly referred to as metabolic zonation. Metabolic zonation is rather dynamic since gene expression patterns of metabolic enzymes may change in response to nutrition, Edited by: drugs, hormones and pathological states of the liver (e.g., fibrosis and inflammation). Steven Dooley, Universitätsmedizin Mannheim, This fact has to be ultimately taken into account in mathematical models aiming at Medizinische Fakultät Mannheim, the prediction of metabolic liver functions in different physiological and pathological Universität Heidelberg, Germany settings. Here we present a spatially resolved kinetic tissue model of hepatic glucose Reviewed by: metabolism which includes zone-specific temporal changes of enzyme abundances Adil Mardinoglu, Chalmers University of Technology, which are driven by concentration gradients of nutrients, hormones and oxygen along Sweden the hepatic sinusoids. As key modulators of enzyme expression we included oxygen, Rolf Gebhardt, Leipzig University, Germany glucose and the hormones insulin and glucagon which also control enzyme activities *Correspondence: by cAMP-dependent reversible phosphorylation.
    [Show full text]
  • The Role of Sirtuin 2 Activation by Nicotinamide Phosphoribosyltransferase in the Aberrant Proliferation and Survival of Myeloid Leukemia Cells
    Acute Myeloid Leukemia Articles and Brief Reports The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells Lan Dan, 1,4 Olga Klimenkova, 1 Maxim Klimiankou, 1 Jan-Henning Klusman, 2 Marry M. van den Heuvel-Eibrink, 3 Dirk Reinhardt, 2 Karl Welte, 1 and Julia Skokowa 1 1Department of Molecular Hematopoiesis, Children’s Hospital, Hannover Medical School, Hannover, Germany; 2Department of Pediatric Hematology and Oncology, Children’s Hospital, Hannover Medical School, Hannover, Germany; and 3Department of Pediatric Oncology and Hematology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands; 4Department of Pediatrics, The First Affiliated Hospital of GuangXi Medical University, NanNing, China ABSTRACT Acknowledgments: we thank Background A. Gigina, A. Müller Brechlin Inhibitors of nicotinamide phosphoribosyltransferase have recently been validated as therapeu - and M. Reuter for their excellent tic targets in leukemia, but the mechanism of leukemogenic transformation downstream of this technical assistance. enzyme is unclear. Manuscript received on Design and Methods September 14, 2011. Revised version arrived on November 21, Here, we evaluated whether nicotinamide phosphoribosyltransferase’s effects on aberrant pro - 2011. Manuscript accepted liferation and survival of myeloid leukemic cells are dependent on sirtuin and delineated the on December 19, 2011. downstream signaling pathways operating during this process. Correspondence: Results Karl Welte, Department of We identified significant upregulation of sirtuin 2 and nicotinamide phosphoribosyltransferase Molecular Hematopoiesis, Hannover levels in primary acute myeloid leukemia blasts compared to in hematopoietic progenitor cells Medical School, Carl-Neuberg from healthy individuals. Importantly, specific inhibition of nicotinamide phosphoribosyltrans - Str. 1, 30625 Hannover, ferase or sirtuin 2 significantly reduced proliferation and induced apoptosis in human acute Germany.
    [Show full text]
  • Physiology, Biochemistry, and Pharmacology of Transporters for Organic Cations
    International Journal of Molecular Sciences Editorial Physiology, Biochemistry, and Pharmacology of Transporters for Organic Cations Giuliano Ciarimboli Experimental Nephrology, Department of Internal Medicine D, University Hospital Münster, 48149 Münster, Germany; [email protected] This editorial summarizes the 13 scientific papers published in the Special Issue “Physiology, Biochemistry, and Pharmacology of Transporters for Organic Cations” of the International Journal of Molecular Sciences. In this Special Issue, the readers will find integrative information on transporters for organic cations. Besides reviews on physi- ology, pharmacology, and toxicology of these transporters [1–3], which offer a concise overview of the field, the readers will find original research work focusing on specific transporter aspects. Specifically, the review “Organic Cation Transporters in Human Physiology, Phar- macology, and Toxicology” by Samodelov et al. [1] summarizes well the general as- pects of physiology, pharmacology, and toxicology of transporter for organic cations. The other review “Organic Cation Transporters in the Lung—Current and Emerging (Patho)Physiological and Pharmacological Concepts” by Ali Selo et al. [2] focuses on these aspects of transporters for organic cations in the lung, an important but often ne- glected field. In the paper “Systems Biology Analysis Reveals Eight SLC22 Transporter Subgroups, Including OATs, OCTs, and OCTNs”, by performing a system biology analysis of SLC22 transporters, Engelhart et al. [4] suggest the existence of a transporter–metabolite network. They propose that, in this network, mono-, oligo-, and multi-specific SLC22 transporters Citation: Ciarimboli, G. Physiology, interact to regulate concentrations and fluxes of many metabolites and signaling molecules. Biochemistry, and Pharmacology of In particular, the organic cation transporters (OCT) subgroup seems to be associated with Transporters for Organic Cations.
    [Show full text]
  • Leeds Thesis Template
    Determining the Link Between Genome Integrity and Seed Quality Robbie Michael Gillett Submitted in accordance with the requirements for the degree of Doctor of Philosophy The University of Leeds Faculty of Biological Sciences School of Biology January, 2017 - ii - The candidate confirms that the work submitted is his own and that appropriate credit has been given where reference has been made to the work of others. This copy has been supplied on the understanding that it is copyright material and that no quotation from the thesis may be published without proper acknowledgement. The right of Robbie M. Gillett to be identified as Author of this work has been asserted by him in accordance with the Copyright, Designs and Patents Act 1988. © 2016 The University of Leeds and Robbie Michael Gillett - iii - Acknowledgements I would like to thank my supervisor Dr Christopher West and co-supervisor Dr. Wanda Waterworth for all of their support, expertise and incredible patience and for always being available to help. I would like to thank Aaron Barrett, James Cooper, Valérie Tennant, and all my other friends at university for their help throughout my PhD. Thanks to Vince Agboh and Grace Hoysteed for their combined disjointedness and to Ashley Hines, Daniel Johnston and Darryl Ransom for being a source of entertainment for many years. I would like to thank my international Sona friends, Lindsay Hoffman and Jan Maarten ten Katen. Finally unreserved thanks to my loving parents who supported me throughout the tough times and to my Grandma and Granddad, Jean and Dennis McCarthy, who were always very vocal with their love, support and pride.
    [Show full text]
  • BIOCHEMISTRY MAJOR the Biochemistry Major Is Offered Through the Department of Chemistry
    BIOCHEMISTRY MAJOR The Biochemistry major is offered through the Department of Chemistry. This sequence is recommended for students planning entry into graduate school in Biochemistry, Pharmacology, or related subjects. It is also strongly recommend for those desiring to pursue medical or dental school. NOTE: This course sequence may be modified to include a Senior Capstone Experience. FIRST YEAR Fall Semester Credits Spring Semester Credits General Chemistry I for Majors (CHE111) 3 General Chemistry II for Majors (CHE112) 3 General Chemistry I Lab for Majors (CHE111L) 1 General Chemistry II Lab for Majors (CHE112L) 1 General Chemistry I Récitation (CHE111R) 0 General Chemistry II Récitation (CHE112R) 0 Precalculus (MAT116 or MAT120) 3-4 Calculus I (MAT231) 4 First Year Composition (ENG103) 4 Foreign Language (FL201) 4 African Diaspora/World I (ADW111) 4 African Diaspora/World II (ADW112) 4 First Year Experience (FYE 101-Chemistry) 1 First Year Experience (FYE 102-Chemistry) 1 First Year Seminar in Chemistry (CHE101) 0 Big Questions Colloquia (BQC) 1 TOTAL HOURS 16-17 TOTAL HOURS 18 SOPHOMORE YEAR Fall Semester Credits Spring Semester Credits Organic Chemistry I for Majors (CHE231) 4 Organic Chemistry II for Majors (CHE232) 4 Organic Chemistry I Lab (CHE233L) 1 Organic Chemistry II Lab (CHE234L) 1 Organic Chemistry I Récitation (CHE233R) 0 Organic Chemistry II Récitation (CHE234R) 0 Biology of the Cell (BIO120) 4 Organismal Form and Function(BIO115) 4 Calculus II (MAT 232) 4 Physics I: Mechanics & Lab (PHY151) 4 Foreign Language (FL202)
    [Show full text]
  • The Microbiota-Produced N-Formyl Peptide Fmlf Promotes Obesity-Induced Glucose
    Page 1 of 230 Diabetes Title: The microbiota-produced N-formyl peptide fMLF promotes obesity-induced glucose intolerance Joshua Wollam1, Matthew Riopel1, Yong-Jiang Xu1,2, Andrew M. F. Johnson1, Jachelle M. Ofrecio1, Wei Ying1, Dalila El Ouarrat1, Luisa S. Chan3, Andrew W. Han3, Nadir A. Mahmood3, Caitlin N. Ryan3, Yun Sok Lee1, Jeramie D. Watrous1,2, Mahendra D. Chordia4, Dongfeng Pan4, Mohit Jain1,2, Jerrold M. Olefsky1 * Affiliations: 1 Division of Endocrinology & Metabolism, Department of Medicine, University of California, San Diego, La Jolla, California, USA. 2 Department of Pharmacology, University of California, San Diego, La Jolla, California, USA. 3 Second Genome, Inc., South San Francisco, California, USA. 4 Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA. * Correspondence to: 858-534-2230, [email protected] Word Count: 4749 Figures: 6 Supplemental Figures: 11 Supplemental Tables: 5 1 Diabetes Publish Ahead of Print, published online April 22, 2019 Diabetes Page 2 of 230 ABSTRACT The composition of the gastrointestinal (GI) microbiota and associated metabolites changes dramatically with diet and the development of obesity. Although many correlations have been described, specific mechanistic links between these changes and glucose homeostasis remain to be defined. Here we show that blood and intestinal levels of the microbiota-produced N-formyl peptide, formyl-methionyl-leucyl-phenylalanine (fMLF), are elevated in high fat diet (HFD)- induced obese mice. Genetic or pharmacological inhibition of the N-formyl peptide receptor Fpr1 leads to increased insulin levels and improved glucose tolerance, dependent upon glucagon- like peptide-1 (GLP-1). Obese Fpr1-knockout (Fpr1-KO) mice also display an altered microbiome, exemplifying the dynamic relationship between host metabolism and microbiota.
    [Show full text]
  • Style Specifications Thesis
    Structural Studies of Salvage Enzymes in Nucleotide Biosynthesis Martin Welin Faculty of Natural Resources and Agricultural Sciences Department of Molecular Biology Uppsala Doctoral thesis Swedish University of Agricultural Sciences Uppsala 2007 Acta Universitatis Agriculturae Sueciae 2007:21 ISSN 1652-6880 ISBN 978-91-576-7320-6 © 2007 Martin Welin, Uppsala Tryck: SLU Service/Repro, Uppsala 2007 Abstract Welin, M., 2007. Structural Studies of Salvage Enzymes in Nucleotide Biosynthesis. Doctoral dissertation. ISSN 1652-6880, ISBN 978-91-576-7320-6 There are two routes to produce deoxyribonucleoside triphosphates (dNTPs) precursors for DNA synthesis, the de novo and the salvage pathways. Deoxyribonucleoside kinases (dNKs) perform the initial phosphorylation of deoxyribonucleosides (dNs). Furthermore, they can act as activators for several medically important nucleoside analogs (NAs) for treatment against cancer or viral infections. Several disorders are characterized by mutations in enzymes involved in the nucleotide biosynthesis, such as Lesch-Nyhan disease that is linked to hypoxanthine guanine phosphoribosyltransferase (HPRT). In this thesis, the structures of human thymidine kinase 1 (TK1), a mycoplasmic deoxyadenosine kinase (Mm-dAK), and phosphoribosyltransferase domain containing 1 (PRTFDC1) are presented. Furthermore, a structural investigation of Drosophila melanogaster dNK (Dm-dNK) N64D mutant was carried out. The obtained structural information reveals the basis for substrate specificity for TKs and the bacterial dAKs. The TK1 revealed a structure different from other known dNK structures, containing an α/β domain similar to the RecA-F1ATPase family, and a lasso-like domain stabilized by a structural zinc. The Mm-dAK structure was similar to its human counterparts, but with some alterations in the proximity of the active site.
    [Show full text]
  • Biochemistry and Molecular Biology
    School of Life Sciences / Department of Biochemistry and Biophysics BIOCHEMISTRY AND MOLECULAR BIOLOGY Revealing how life works Department of Biochemistry and Biophysics Oregon State University 2011 Agriculture and Life Sciences Building Corvallis, OR 97331 OSUBB 541-737-4511 biochem.oregonstate.edu College of Science Oregon State University 128 Kidder Hall Corvallis, OR 97331 541-737-4811 science.oregonstate.edu This publication will be made available in an accessible alternative format upon request. Please contact the College COLLEGE OF SCIENCE of Science at 541-737-4811 or [email protected]. ACADEMIC BROCHURE / 2020 Highlights • Solve problems at the What will you discover? intersection of biological and physical sciences with our The Department of Biochemistry and Biophysics offers nationally accredited program world-class faculty, a tradition of interdisciplinary in biochemistry, molecular and research, teaching excellence and extraordinary cellular biology, chemistry, laboratories to facilitate undergraduate learning. molecular genetics, physics and statistics. The department ranks high nationally and internationally in many research areas, including signal transduction, gene • Tailor your education to expression, epigenetics, metabolic regulation, structural specific career goals with three biology, and genetic code expansion technology. different options. The department offers two Bachelor of Science degrees, • Thrive in a smaller, supportive both accredited by the American Society for Biochemistry department within a world-class and Molecular Biology (ASBMB): research university. • Biochemistry and Molecular Biology (BMB) with • Pursue interdisciplinary research options in Advanced Molecular Biology, Computational projects with faculty across OSU. Molecular Biology, and Pre-medicine; • Participate in the Biochemistry • Biochemistry and Biophysics (BB) with options in Club for community, leadership Advanced Biophysics, Neuroscience, and Pre-medicine.
    [Show full text]
  • And Even-Length, Medium-Chain Fatty Acids in Plants (Amino Adds/Elongtin) ANTOANETA B
    Proc. Nadl. Acad. Sci. USA Vol. 91, pp. 11437-11441, November 1994 Biochemistry A pathway for the biosynthesis of straight and branched, odd- and even-length, medium-chain fatty acids in plants (amino adds/elongtin) ANTOANETA B. KROUMOVA, ZHIYI XIE, AND GEORGE J. WAGNER* Plant Physiology/Biochemistry/Molecular Biology Program, Agronomy Department, University of Kentucky, Lexington, KY 40546-0091 Communicated by Martin Gibbs, July 25, 1994 ABSTRACT Pathways and enzymes offatty acid synthase- and even-length scFAs are synthesized via modified mediated, long-even-chain (generally C16-C20) fatty add syn- branched-chain amino acid (bcAA) metabolism in tobacco thesis are well studied, and general metabolism involved in trichome glands (6, 7). It is possible that at least branched and short-chain (Cs-C7) fatty acid biosynthesis is also understood. odd-length mcFAs are formed in this tissue similarly. Alter- In contrast, mechanism of medinm-chain (C#-C14) fatty acid natively, primers derived from bcAA metabolism may be synthesis are unclear. Recent work suggests involvement of elongated by fatty acid synthase (FAS), as suggested for chain-elongation-terminating thloesterases in medium-chain tomato trichomes (8) and tobacco epidermis (9). fatty acid formation in oilseeds and animals. We have shown The classical pathway for bcAA (Val, Leu, Ileu) biosyn- that iso- and anteiso-branched and straigbt, odd- and even- thesis in microorganisms (and largely by inference in plants, length, short-chain fatty adds esterifled in plant-trichome- ref. 10) is shown in the shaded areas of Fig. 1. Key activities gland-produced sucrose esters are synthesized by using carbon involved in branched-chain formation (reactions 1, 1A, and 2) skeletons provided by modified branched-chain amino acid are those catalyzing leucine biosynthesis in all organisms and metabolism/catablis.
    [Show full text]
  • Biochemical Basis for Differential Deoxyadenosine Toxicity To
    Proc. Natl. Acad. Sci. USA Vol. 76, No. 5, pp. 2434-2437, May 1979 Medical Sciences Biochemical basis for differential deoxyadenosine toxicity to T and B lymphoblasts: Role for 5'-nucleotidase (deoxyadenosine kinase/deoxyadenylate kinase/immunodeficiency) ROBERT L. WORTMANN, BEVERLY S. MITCHELL, N. LAWRENCE EDWARDS, AND IRVING H. Fox Human Purine Research Center, Departments of Internal Medicine and Biological Chemistry, Clinical Research Center, University of Michigan Medical Center, Ann Arbor, Michigan 48109 Communicated by James B. Wyngaarden, March 7, 1979 ABSTRACT Deoxyadenosine metabolism was investigated tained from Calbiochem. Erythro-9-[3-(2-hydroxynonyl)]- in cultured human cells to elucidate the biochemical basis for adenine (EHNA) was a gift from G. B. Elion of Burroughs the sensitivity of T lymphoblasts and the resistance of B lym- Wellcome (Research Triangle Park, NC). Horse serum was phoblasts to deoxyadenosine toxicity. T lymphoblasts have a 20- to 45-fold greater capacity to synthesize deoxyadenosine nu- obtained from Flow Laboratories (Rockville, MD), and Eagle's cleotides than B lymphoblasts at deoxyadenosine concentrations minimal essential medium was purchased from GIBCO. From of 50-300 ,uM. During the synthesis of dATP, T lymphoblasts Amersham/Searle, [U-14C]deoxyadenosine (505 mCi/mmol), accumulate large quantities of dADP, whereas B lymphoblasts [8-14C]hypoxanthine (52.5 mCi/mmol), and [U-14C]deoxy- do not accumu ate dADP. Enzymes affecting deoxyadenosine adenosine monophosphate (574 mCi/mmol) were purchased; nucleotide synthesis were assayed in these cells. No substantial and, from ICN, [8-14C]adenosine monophosphate (34.4 mCi/ differences were evident in activities of deoxyadenosine kinase (ATP: deoxyadenosine 5'-phosphotransferase, EC 2.7.1.76) or mmol) was purchased (1 Ci = 3.7 X 1010 becquerels).
    [Show full text]
  • Biochemistry Major University of Michigan - Department of Chemistry Effective 9/2017 ______
    Biochemistry Major University of Michigan - Department of Chemistry Effective 9/2017 _____________________________________________________________________________________________ Biochemistry is, literally the chemistry of life. Biochemists seek to understand the chemical principles that underpin all living organisms. Biochemistry is central to medical science as almost all diseases and drugs act to change the body’s chemistry. Advances in biochemistry directly impact the fields of biotechnology, pharmaceutical science, agriculture and environmental science, among many others. The B.S. major in Biochemistry is for those are interested in learning about life from a chemical perspective. Students will be well equipped for graduate studies in biochemistry, chemical biology, and many other fields of inquiry in the life sciences. The degree will also provide excellent preparation for students intending to pursue professional careers in industry and medicine. Prerequisites Course # Course Description Term Term Credits Completed Typically Offered CHEM 210 Structure and Reactivity I F, W, Sp 4 CHEM 211 Investigations in Chemistry: Laboratory F, W, Sp 1 CHEM 215 Structure and Reactivity II F, W, Sp 3 BIO 171 Introductory Biology: Ecology and Evolution F, W, Sp, Su 4 BIO 172 Introductory Biology: Molecular Cellular and Developmental F, W, Sp 4 MATH 115 Calculus I F, W, Sp, Su 4 MATH 116 Calculus II F, W, Sp, Su 4 One of the Following: CHEM 262 Mathematical Methods for Chemists F, W 4 OR MATH 215 Calculus III F, W, Sp, Su 4 One of the Following
    [Show full text]
  • Chem331 Glycogen Metabolism
    Glycogen metabolism Glycogen review - 1,4 and 1,6 α-glycosidic links ~ every 10 sugars are branched - open helix with many non-reducing ends. Effective storage of glucose Glucose storage Liver glycogen 4.0% 72 g Muscle glycogen 0.7% 245 g Blood Glucose 0.1% 10 g Large amount of water associated with glycogen - 0.5% of total weight Glycogen stored in granules in cytosol w/proteins for synthesis, degradation and control There are very different means of control of glycogen metabolism between liver and muscle Glycogen biosynthetic and degradative cycle Two different pathways - which do not share enzymes like glycolysis and gluconeogenesis glucose -> glycogen glycogenesis - biosynthetic glycogen -> glucose 1-P glycogenolysis - breakdown Evidence for two paths - Patients lacking phosphorylase can still synthesize glycogen - hormonal regulation of both directions Glycogenolysis (glycogen breakdown)- Glycogen Phosphorylase glycogen (n) + Pi -> glucose 1-p + glycogen (n-1) • Enzyme binds and cleaves glycogen into monomers at the end of the polymer (reducing ends of glycogen) • Dimmer interacting at the N-terminus. • rate limiting - controlled step in glycogen breakdown • glycogen phosphorylase - cleavage of 1,4 α glycosidic bond by Pi NOT H2O • Energy of phosphorolysis vs. hydrolysis -low standard state free energy change -transfer potential -driven by Pi concentration -Hydrolysis would require additional step s/ cost of ATP - Think of the difference between adding a phosphate group with hydrolysis • phosphorylation locks glucose in cell (imp. for muscle) • Phosphorylase binds glycogen at storage site and the catalytic site is 4 to 5 glucose residues away from the catalytic site. • Phosphorylase removes 1 residue at a time from glycogen until 4 glucose residues away on either side of 1,6 branch point – stericaly hindered by glycogen storage site • Cleaves without releasing at storage site • general acid/base catalysts • Inorganic phosphate attacks the terminal glucose residue passing through an oxonium ion intermediate.
    [Show full text]